Hao Xi Ede
Director/Board Member presso DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED
Patrimonio netto: 20 M $ in data 31/03/2024
Profilo
Attualmente, Hao Xi Ede occupa la posizione di direttore finanziario e direttore esecutivo presso Innovent Biologics, Inc. Il signor Ede fa anche parte del consiglio di Mindray Medical International Ltd. e Dawnrays Pharmaceutical Holdings Ltd. ed è membro dell'Institute of Singapore Chartered Accountants. In passato il signor Ede è stato direttore finanziario di Viavi Solutions, Inc., direttore finanziario e segretario di Biosensors International Group Ltd., direttore finanziario e amministratore di Mindray Medical International Ltd., amministratore delegato dell'Asia di FUJIFILM SonoSite, Inc. e direttore marketing di Ernst & Young (Cina). Hao Xi Ede ha conseguito una laurea presso la University of Hawai'i at Hilo e un MBA presso la University of Washington.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
INNOVENT BIOLOGICS, INC.
0.25% | 22/03/2024 | 4 073 616 ( 0.25% ) | 20 M $ | 31/03/2024 |
Posizioni attive di Hao Xi Ede
Società | Posizione | Inizio |
---|---|---|
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED | Director/Board Member | 15/06/2015 |
INNOVENT BIOLOGICS, INC. | Director/Board Member | 04/06/2018 |
Institute of Singapore Chartered Accountants
Institute of Singapore Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Institute of Singapore Chartered Accountants provides accounting services. | Corporate Officer/Principal | - |
Precedenti posizioni note di Hao Xi Ede
Società | Posizione | Fine |
---|---|---|
MINDRAY MEDICAL INTERNATIONAL LTD (ADR) | Director/Board Member | 18/05/2023 |
BIOSENSORS INTERNATIONAL GROUP LTD | Director of Finance/CFO | 01/01/2016 |
MINDRAY MEDICAL INTERNATIONAL LTD (ADR) | Director of Finance/CFO | 01/01/2011 |
VIAVI SOLUTIONS INC. | Director of Finance/CFO | 01/01/2008 |
Ernst & Young (China) | Sales & Marketing | 01/01/2003 |
Formazione di Hao Xi Ede
University of Washington | Masters Business Admin |
University of Hawai'i at Hilo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
VIAVI SOLUTIONS INC. | Technology Services |
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED | Health Technology |
INNOVENT BIOLOGICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
FUJIFILM SonoSite, Inc.
FUJIFILM SonoSite, Inc. Medical SpecialtiesHealth Technology FUJIFILM SonoSite, Inc. engages in the developing, manufacturing and marketing of in hand-carried ultrasound systems, which are used in a variety of medical specialties in a range of clinical settings at the point-of-care. It designs products for applications, including emergency medicine, surgery, critical care, internal medicine, musculoskeletal, and vascular access procedures as well as for imaging in traditional applications, such as radiology, cardiology, vascular medicine and obstetrics and gynecology. The company was founded in April 1998 and is headquartered in Bothell, WA. | Health Technology |
Biosensors International Group Ltd.
Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
Mindray Medical International Ltd.
Mindray Medical International Ltd. Medical SpecialtiesHealth Technology Mindray Medical International Ltd. is a holding company that engages in the development, manufacture, and distribution of medical devices. Its products include orthopedic and endoscopic devices and healthcare information technology solutions. The company operates through the following segments: Patient Monitoring and Life Support, In-vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Supports Products segments includes patient monitoring devices which tracks the physiological parameters of patients such as heart rate, blood pressure, respiration and temperature for adult, pediatric, and neonatal patients for hospital intensive care units, operating rooms, and emergency rooms; and the life support products are to provide operation room or intensive care unit solutions for the end-users in the operating room. Its products include single- and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring devices for patient monitoring devices, and anesthesia machines, defibrillators, surgical beds, surgical lights ceiling pendants, syringes, and infusion pumps, and ventilators for the life supports products. The In-vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples. It offers hematology, biochemistry, urine sediment, microbiology, and coagulation analyzers, and reagents. The Medical Imaging Systems segment includes ultrasound, digital radiography, and magnetic resonance imaging systems. The company was founded by Xu Hang and Li Xi Ting on June 10, 2005 and is headquartered in Shenzhen, China. | Health Technology |
Institute of Singapore Chartered Accountants
Institute of Singapore Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Institute of Singapore Chartered Accountants provides accounting services. | Commercial Services |
Ernst & Young (China) |
- Borsa valori
- Insiders
- Hao Xi Ede